| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 600 | $217.07 | $130,242.37 | -0.1% | -18.5% | +24.7% | |
| Apr 1, 2024 | Olson Laurie J77 | Director | Sell | 1,000 | $23.50 | $23,500.00 | -6.2% | -46.7% | -72.0% | ||
| Mar 28, 2024 | DXCM Dexcom Inc | Brown Michael Jon72 | EVP Chief Legal Officer | Sell | 2,624 | $140.04 | $367,472.37 | -1.9% | -18.2% | -51.2% | |
| Mar 28, 2024 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 77,136 | $9.44 | $727,853.40 | -15.5% | -36.4% | -61.1% | |
| Mar 27, 2024 | DXR Daxor Corp | Michel Robert J61 | Chief Financial Officer | Buy | 750 | $8.70 | $6,525.00 | +7.1% | +11.9% | -5.5% | |
| Mar 27, 2024 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 515 | $17.99 | $9,264.85 | -0.4% | +15.7% | +41.8% | |
| Mar 27, 2024 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 454 | $17.99 | $8,167.46 | -0.1% | +15.7% | +41.8% | |
| Mar 27, 2024 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 395 | $17.99 | $7,106.05 | -0.2% | +15.7% | +41.8% | |
| Mar 26, 2024 | DXR Daxor Corp | Feldschuh Michael Richard75 | Chief Executive Office | Buy | 1,000 | $8.13 | $8,130.00 | +0.5% | +8.5% | -6.6% | |
| Mar 26, 2024 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 21,438 | $9.55 | $204,732.90 | -13.0% | -31.8% | -58.6% | |
| Mar 26, 2024 | MXCT Maxcyte, Inc. | Johnston John Joseph75 | Director | Sell | 5,000 | $4.41 | $22,025.00 | -4.0% | -3.5% | -35.9% | |
| Mar 26, 2024 | SONX Sonendo, Inc. | Chen Roy T | Chief Talent Officer | Sell | 2,625 | $0.10 | $273.79 | -1.1% | - | - | |
| Mar 26, 2024 | SONX Sonendo, Inc. | Bergheim Bjarne | President And CEO | Sell | 11,493 | $0.10 | $1,198.72 | -0.6% | - | - | |
| Mar 26, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 5,096 | $1.18 | $6,023.98 | - | -4.2% | -36.1% | |
| Mar 26, 2024 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya75 | Chief Executive Officer | Sell | 38,899 | $9.37 | $364,483.63 | -4.1% | -31.8% | -58.6% | |
| Mar 26, 2024 | SERA Sera Prognostics, Inc. | Aerts Austin77 | Chief Financial Officer | Sell | 8,092 | $9.37 | $75,822.04 | -2.4% | -31.8% | -58.6% | |
| Mar 25, 2024 | INSP Inspire Medical Systems, Inc. | Griffin Jerry C84 | Director | Sell | 554 | $197.81 | $109,586.74 | -2.5% | -34.1% | -19.6% | |
| Mar 25, 2024 | BFLY Butterfly Network, Inc. | Stoica Andrei G53 | Chief Technology Officer | Sell | 3,298 | $1.03 | $3,380.45 | -0.2% | -9.9% | +161.5% | |
| Mar 25, 2024 | DXCM Dexcom Inc | Stern Sadie72 | EVP Chief Human Resources | Sell | 4,137 | $140.00 | $579,180.00 | -5.1% | -21.1% | -47.5% | |
| Mar 25, 2024 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 22,163 | $9.10 | $201,683.30 | -11.8% | -29.2% | -55.7% | |
| Mar 25, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 3,612 | $1.21 | $4,367.99 | - | -6.5% | -37.6% | |
| Mar 22, 2024 | INSP Inspire Medical Systems, Inc. | Rondoni John79 | Chief Technology Officer | Sell | 4,387 | $194.40 | $852,849.02 | -10.4% | -15.0% | -16.4% | |
| Mar 22, 2024 | LUNG Pulmonx Corp | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 1,184 | $9.36 | $11,082.24 | -0.4% | -36.8% | -15.6% | |
| Mar 22, 2024 | BVS Bioventus Inc. | Singleton Mark Leonard46 | SVP &CFO | Sell | 5,541 | $5.39 | $29,852.69 | -17.8% | +2.9% | +77.4% | |
| Mar 21, 2024 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 520 | $17.83 | $9,271.60 | -0.4% | +14.1% | +36.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.